These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2137279)

  • 1. Usefulness of nicorandil in congestive heart failure.
    Galié N; Varani E; Maiello L; Boriani G; Boschi S; Binetti G; Magnani B
    Am J Cardiol; 1990 Feb; 65(5):343-8. PubMed ID: 2137279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of oral nicorandil in congestive heart failure.
    Tice FD; Binkley PF; Cody RJ; Moeschberger ML; Mohrland JS; Wolf DL; Leier CV
    Am J Cardiol; 1990 Jun; 65(20):1361-7. PubMed ID: 2140489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of single-dose nicorandil in coronary artery disease.
    Coltart DJ; Signy M
    Am J Cardiol; 1989 Jun; 63(21):34J-39J. PubMed ID: 2525323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
    Tsutamoto T; Kinoshita M; Nakae I; Maeda Y; Wada A; Yabe T; Horie H
    Am Heart J; 1994 Apr; 127(4 Pt 1):866-73. PubMed ID: 8154425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
    Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
    Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
    Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
    Hayata N; Araki H; Nakamura M
    Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
    Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
    Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
    Camm AJ; Maltz MB
    Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of nicorandil in patients with congestive heart failure.
    Tice FD; Jungbluth GL; Binkley PF; MacKichan JJ; Mohrland JS; Wolf DL; Leier CV
    Clin Pharmacol Ther; 1992 Nov; 52(5):496-503. PubMed ID: 1424424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris.
    Meany TB; Richardson P; Camm AJ; Coltart J; Griffith M; Maltz MB; Signy M
    Am J Cardiol; 1989 Jun; 63(21):66J-70J. PubMed ID: 2525329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicorandil on kinetics of oxygen uptake at the onset of exercise in patients with coronary artery disease.
    Koike A; Hiroe M; Yajima T; Adachi H; Shimizu N; Kano H; Sugimoto K; Miyahara Y; Korenaga M; Marumo F
    Am J Cardiol; 1995 Sep; 76(7):449-52. PubMed ID: 7653442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation.
    Minami Y; Nagashima M; Kajimoto K; Shiga T; Hagiwara N
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):335-40. PubMed ID: 19687747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.